Pfizer-BioNTech COVID-19 shot cleared for adolescents in US
WASHINGTON - Pfizer Inc. and BioNTech SE's COVID-19 vaccine was cleared for use in children age 12 to 15 in the U.S., paving the way for the mass vaccination of ... Click to Contin…
WASHINGTON - Pfizer Inc. and BioNTech SE's COVID-19 vaccine was cleared for use in children age 12 to 15 in the U.S., paving the way for the mass vaccination of ... Click to Contin…